The Culprit Valve: A New Concept for Reducing the Risk of Intervention in Patients with Severe Valve Disease.
作者信息
Aragão Roberto Cintra de Azevedo, Barreto-Filho José Augusto Soares, Sampaio Roney Orismar
机构信息
Universidade Federal de Sergipe, São Cristóvão, SE - Brasil.
Fundação São Lucas, Centro de Ensino e Pesquisa, Aracaju, SE - Brasil.
出版信息
Arq Bras Cardiol. 2025 Apr;122(4):e20240492. doi: 10.36660/abc.20240492.
Abstract
摘要
相似文献
1
The Culprit Valve: A New Concept for Reducing the Risk of Intervention in Patients with Severe Valve Disease.致病瓣膜：降低重症瓣膜病患者干预风险的新概念。
Arq Bras Cardiol. 2025 Apr;122(4):e20240492. doi: 10.36660/abc.20240492.
2
Complete versus culprit-only revascularisation in ST elevation myocardial infarction with multi-vessel disease.ST段抬高型心肌梗死合并多支血管病变时完全血运重建与仅罪犯血管血运重建的比较
Cochrane Database Syst Rev. 2017 May 3;5(5):CD011986. doi: 10.1002/14651858.CD011986.pub2.
3
Meta-analysis of longitudinal comparison of transcatheter versus surgical aortic valve replacement in patients at low to intermediate surgical risk.低至中度手术风险患者经导管主动脉瓣置换术与外科主动脉瓣置换术纵向比较的荟萃分析。
Int J Surg. 2024 Dec 1;110(12):8097-8106. doi: 10.1097/JS9.0000000000002158.
4
Health Related Quality of Life (HRQoL) after transcatheter aortic valve implantation in aortic stenosis patients: exploring a novel threshold for clinically significant improvement after 12 months.主动脉瓣狭窄患者经导管主动脉瓣植入术后的健康相关生活质量（HRQoL）：探索12个月后具有临床显著改善的新阈值。
J Patient Rep Outcomes. 2025 May 26;9(1):58. doi: 10.1186/s41687-025-00894-1.
5
Limited versus full sternotomy for aortic valve replacement.主动脉瓣置换术的有限胸骨切开术与全胸骨切开术对比
Cochrane Database Syst Rev. 2017 Apr 10;4(4):CD011793. doi: 10.1002/14651858.CD011793.pub2.
6
Limited versus full sternotomy for aortic valve replacement.主动脉瓣置换术的有限与全胸骨切开术。
Cochrane Database Syst Rev. 2023 Dec 6;12(12):CD011793. doi: 10.1002/14651858.CD011793.pub3.
7
Study protocol for an internahaational prospective non-randomised trial evaluating the long-term outcomes of transcatheter aortic valve implantation versus surgical aortic valve replacement for aortic-valve stenosis in patients at risk to severe valve obstruction: the TAVISAR trial.一项国际前瞻性非随机试验的研究方案，该试验旨在评估经导管主动脉瓣植入术与外科主动脉瓣置换术治疗有严重瓣膜狭窄风险的主动脉瓣狭窄患者的长期疗效：TAVISAR试验
BMJ Open. 2025 May 24;15(5):e101417. doi: 10.1136/bmjopen-2025-101417.
8
Long-Term Outcomes of Valve Replacement With Mechanical Prosthesis in Patients With Valvular Heart Disease: A Single-Center Retrospective Study.心脏瓣膜病患者机械瓣膜置换术的长期结局：一项单中心回顾性研究
Cureus. 2025 May 22;17(5):e84655. doi: 10.7759/cureus.84655. eCollection 2025 May.
9
CT Angiography for the Detection of Coronary Artery Stenoses in Patients Referred for Cardiac Valve Surgery: Systematic Review and Meta-Analysis.CT 血管造影术在心脏瓣膜手术患者冠状动脉狭窄检测中的应用：系统评价和荟萃分析。
JACC Cardiovasc Imaging. 2016 Sep;9(9):1059-1070. doi: 10.1016/j.jcmg.2015.09.028. Epub 2016 Jun 22.
10
Regression of Left Ventricular Hypertrophy After Aortic Valve Replacement with Sorin Freedom Solo and St. Jude Regent Valves: a Comparative Study.使用索林Freedom Solo瓣膜和圣犹达Regent瓣膜进行主动脉瓣置换术后左心室肥厚的消退：一项比较研究。
Acta Inform Med. 2025;33(2):123-128. doi: 10.5455/aim.2025.33.123-128.
本文引用的文献
1
Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions in collaboration with the ESC Working Group on Cardiovascular Surgery.经导管主动脉瓣植入术患者的冠状动脉疾病管理。欧洲经皮心血管介入协会与 ESC 心血管外科学工作组合作的临床共识声明。
EuroIntervention. 2023 May 15;19(1):37-52. doi: 10.4244/EIJ-D-22-00958.
2
Surgical versus Interventional Treatment of Concomitant Aortic Valve Stenosis and Coronary Artery Disease.手术治疗与介入治疗伴发主动脉瓣狭窄和冠状动脉疾病。
Thorac Cardiovasc Surg. 2023 Dec;71(8):620-631. doi: 10.1055/a-2003-2105. Epub 2022 Dec 22.
3
Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation.经导管主动脉瓣植入术患者稳定型冠状动脉疾病的血运重建管理。
Circ Cardiovasc Interv. 2022 Dec;15(12):e012417. doi: 10.1161/CIRCINTERVENTIONS.122.012417. Epub 2022 Dec 20.
4
Optimal timing for percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation.经导管主动脉瓣植入术患者行经皮冠状动脉介入治疗的最佳时机。
Int J Cardiol. 2022 Oct 15;365:114-122. doi: 10.1016/j.ijcard.2022.07.030. Epub 2022 Jul 21.
5
When Aortic Stenosis Is Not Alone: Epidemiology, Pathophysiology, Diagnosis and Management in Mixed and Combined Valvular Disease.当主动脉瓣狭窄并非孤立存在时：混合性和联合性瓣膜病的流行病学、病理生理学、诊断与管理
Front Cardiovasc Med. 2021 Oct 15;8:744497. doi: 10.3389/fcvm.2021.744497. eCollection 2021.
6
Trend and Impact of Concomitant CABG and Multiple-Valve Procedure on In-hospital Outcomes of SAVR Patients.同期冠状动脉旁路移植术（CABG）与多瓣膜手术对主动脉瓣置换术（SAVR）患者院内结局的影响及趋势
Front Cardiovasc Med. 2021 Sep 3;8:740084. doi: 10.3389/fcvm.2021.740084. eCollection 2021.
7
2021 ESC/EACTS Guidelines for the management of valvular heart disease.2021年欧洲心脏病学会/欧洲心胸外科学会瓣膜性心脏病管理指南。
Eur Heart J. 2022 Feb 12;43(7):561-632. doi: 10.1093/eurheartj/ehab395.
8
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020美国心脏病学会/美国心脏协会瓣膜性心脏病患者管理指南：美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2021 Feb 2;143(5):e72-e227. doi: 10.1161/CIR.0000000000000923. Epub 2020 Dec 17.
9
Update of the Brazilian Guidelines for Valvular Heart Disease - 2020.《巴西心脏瓣膜病指南（2020年版）》更新
Arq Bras Cardiol. 2020 Oct;115(4):720-775. doi: 10.36660/abc.20201047.
10
Double transcatheter balloon-expandable valve implantation for severe valve dysfunction in high-risk patients: initial experience.双球囊经导管扩张瓣膜植入术治疗高危患者重度瓣膜功能障碍：初步经验。
Interact Cardiovasc Thorac Surg. 2020 Oct 1;31(4):461-466. doi: 10.1093/icvts/ivaa142.
Zotero 插件